Although COVID-19 vaccines can induce high titers of neutralizing IgG and IgA class antibodies against the SARS-CoV-2 spike protein, they only offer temporary protection against the SARS-CoV-2 infection [1,111,112,113]. The gene discussed is CD79A; the disease is COVID-19.